RECOVERY OF HORMONE-SECRETION AFTER CHRONIC GONADOTROPIN-RELEASING HORMONE AGONIST ADMINISTRATION IN WOMEN WITH POLYCYSTIC OVARIAN DISEASE

被引:44
|
作者
DEZIEGLER, D
STEINGOLD, K
CEDARS, M
LU, JKH
MELDRUM, DR
JUDD, HL
CHANG, RJ
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, DEPT OBSTET, LOS ANGELES, CA 90024 USA
[2] UNIV CALIF LOS ANGELES, SCH MED, DEPT GYNECOL, LOS ANGELES, CA 90024 USA
来源
关键词
D O I
10.1210/jcem-68-6-1111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 50 条
  • [31] Hormonal and clinical effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome
    Szilágyi, A
    Homoki, J
    Bellyei, S
    Szabó, I
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2000, 14 (05) : 337 - 341
  • [32] Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
    Sattler, Lisa-Marie
    Schniewind, Hanna A.
    Minich, Waldemar B.
    Haudum, Christoph W.
    Niklowitz, Petra
    Muenzker, Julia
    Kovacs, Gabor L.
    Reinehr, Thomas
    Obermayer-Pietsch, Barbara
    Schomburg, Lutz
    [J]. PLOS ONE, 2021, 16 (04):
  • [33] PITUITARY AND OVARIAN SUPPRESSION RATE AFTER HIGH DOSAGE OF GONADOTROPIN-RELEASING HORMONE AGONIST
    BIDER, D
    GOLDENBERG, M
    BENRAFAEL, Z
    MASHIACH, S
    SHALEV, J
    BLANKSTEIN, J
    [J]. FERTILITY AND STERILITY, 1989, 51 (04) : 578 - 581
  • [34] THE RESPONSE OF PATIENTS WITH POLYCYSTIC OVARIAN DISEASE TO HUMAN MENOPAUSAL GONADOTROPIN THERAPY AFTER OVARIAN ELECTROCAUTERY OR A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST
    GADIR, AA
    ALNASER, HMI
    MOWAFI, RS
    SHAW, RW
    [J]. FERTILITY AND STERILITY, 1992, 57 (02) : 309 - 313
  • [35] Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
    Shin, Jae Jun
    Choi, Young Min
    Jun, Jong Kwan
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Wonshik
    Im, Seock-Ah
    [J]. JOURNAL OF BREAST CANCER, 2020, 23 (03) : 268 - 278
  • [36] Spontaneous expulsion of a uterine submucosal leiomyoma after administration of a gonadotropin-releasing hormone agonist
    Yu, KJ
    Lai, CR
    Sheu, MH
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 96 (02): : 223 - 225
  • [37] Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest
    Matsushima, Takashi
    Akira, Shigeo
    Yoneyama, Koichi
    Takeshita, Toshiyuki
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (06) : 521 - 524
  • [38] A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
    Zhou Feng
    Jin Xiao-Ying
    Yang Cui-Yu
    Zhang Song-Ying
    [J]. 中华医学杂志(英文版), 2016, (06) : 746 - 748
  • [39] A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
    Zhou, Feng
    Jin, Xiao-Ying
    Yang, Cui-Yu
    Zhang, Song-Ying
    [J]. CHINESE MEDICAL JOURNAL, 2016, 129 (06) : 746 - 748
  • [40] Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration
    Seyhan, Ayse
    Ata, Baris
    Sidal, Bilhan
    Urman, Bulent
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (02): : 526 - 528